Agenus announces reverse stock split of common stock

Lexington, mass.--(business wire)--agenus inc. (nasdaq: agen), a leader in discovering and developing novel immunological agents to treat various cancers, today announced its stockholders have approved a one-for-twenty reverse stock split of its issued and outstanding common stock, which will go into effect at 12:01 a.m., eastern time on april 12, 2024. the reverse stock split is intended to give agenus greater flexibility in its future financing needs and to increase the per share trading pric.
AGEN Ratings Summary
AGEN Quant Ranking